ArticleJournal of loss prevention in the process industries2021
The impact of the COVID-19 pandemic on the safety management in Italian Seveso industries.
Article in Journal of loss prevention in the process industries, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Quantifying resilience potentials in construction: pilot evaluation of the resilience assessment grid.Frontiers in public health · 2025Article
- Article
- Performance assessment and improvement of a care unit for COVID-19 patients with resilience engineering and motivational factors: An artificial neural network method.Computers in biology and medicine · 2022Article
- The applications of MCDM methods in COVID-19 pandemic: A state of the art review.Applied soft computing · 2022Review
- Special issue: Process safety in times of a pandemic.Journal of loss prevention in the process industries · 2022Article
- Ten GIS-Based Solutions for Managing and Controlling COVID-19 Pandemic Outbreak.SN computer science · 2022Review
- Deep learning model for forecasting COVID-19 outbreak in Egypt.Process safety and environmental protection : transactions of the Institution of Chemical Engineers, Part B · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The paper discusses the impact of the COVID-19 pandemic on the Italian chemical and process industries, where Directive 2012/18/EU Seveso III, for the control of Major Accident Hazard (MAH), is enforced. The Safety Management System (SMS) for the control of MAH, which has been mandatory for 20 years in Italian Seveso Establishments, has been highly stressed by the external pressure, related in some way to the COVID-19 pandemic. Fairly, most companies, in particular in oil and gas sectors, have demonstrated an adequate capability to reconcile operation continuity and health requirements. This experience is providing the establishment operators and the regulators with valuable suggestions for the improvements of the SMS-MAH. Within this framework, an innovative organisational resilience model is proposed, aiming at the development of a higher capability to face future new crisis. The current SMS-MAH already includes some basic pillars to enhance resilience, which were valuable during the pandemic crisis, but a full and rationale development is still needed. Starting from the first pandemic phase experience, this paper presents a novel tool to assess the degree of "resilience" of a SMS-MAH. It is based on a questionnaire, featuring 25 questions grouped into eight items, according to the typical SMS-MAH structure. A two level AHP model has been developed in order to define the weights to be assigned to each point. The AHP panel included industrial practitioners, regulators, authorities and researchers. The results are based on the COVID-19 experience and consequently the developed model is tailored to face health emergencies, but the approach may be easily transferred to other external crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.